Cargando…
MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
Medulloblastoma (MB) is the most common paediatric malignant brain tumour and is classified into four distinct molecular subgroups (WNT, SHH, G3 and G4), each of them further subdivided into subtypes with different prognosis and responses to therapy. Deregulation of chromatin modifier genes play an...
Autores principales: | Badodi, Sara, Pomella, Nicola, Zhang, Xinyu, Zabet, Nicolae Radu, Basson, M Albert, Marino, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165212/ http://dx.doi.org/10.1093/neuonc/noac079.397 |
Ejemplares similares
-
MEDB-83. A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
por: Raju, Praveen, et al.
Publicado: (2022) -
MEDB-33. The landscape of ecDNA in medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022) -
MEDB-01. Management of the risk of medulloblastoma associated to familial adenomatous polyposis and dysregulated Wnt signalosome
por: Abdelmoula, Balkiss, et al.
Publicado: (2022) -
MEDB-67. Subgroup specific analysis of cellular metabolism in medulloblastoma
por: Funke, Viktoria, et al.
Publicado: (2022) -
MEDB-31. THE CLINICAL SIGNIFICANCE OF EXTENT OF RESECTION IN MEDULLOBLASTOMA
por: Keeling, Claire, et al.
Publicado: (2022)